{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:11:20Z","timestamp":1789906280140,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T00:00:00Z","timestamp":1520035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00520-018-4130-4","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T09:01:33Z","timestamp":1520067693000},"page":"2763-2767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The impact of UGT2B7 C802T and CYP3A4*1G polymorphisms on pain relief in cancer patients receiving oxycontin"],"prefix":"10.1007","volume":"26","author":[{"given":"Jingwen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,3]]},"reference":[{"key":"4130_CR1","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s11136-010-9738-x","volume":"19","author":"Q Shi","year":"2010","unstructured":"Shi Q, Cleeland CS, Klepstad P, Miaskowski C, Pedersen NL (2010) Biological pathways and genetic variables involved in pain. Qual Life Res 19:1407\u20131417","journal-title":"Qual Life Res"},{"key":"4130_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2133\/dmpk.23.223","volume":"23","author":"K Maeda","year":"2008","unstructured":"Maeda K, Sugiyama Y (2008) Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. Drug Metab Pharmacokinet 23:223\u2013235","journal-title":"Drug Metab Pharmacokinet"},{"key":"4130_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2174\/1389200003339171","volume":"1","author":"CD King","year":"2000","unstructured":"King CD, Rios GR, Green MD, Tephly TR (2000) UDP-glucuronosyltransferases. Curr Drug Metab 1:143\u2013161","journal-title":"Curr Drug Metab"},{"key":"4130_CR4","first-page":"1","volume":"25","author":"BL Coffman","year":"1997","unstructured":"Coffman BL, Rios GR, King CD, Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1\u20134","journal-title":"Drug Metab Dispos"},{"key":"4130_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s12272-011-1104-1","volume":"34","author":"HD Yoo","year":"2011","unstructured":"Yoo HD, Lee YB (2011) Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes. Arch Pharm Res 34:1817\u20131828","journal-title":"Arch Pharm Res"},{"key":"4130_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/11539950-000000000-00000","volume":"31","author":"J Gronlund","year":"2011","unstructured":"Gronlund J, Saari TI, Hagelberg NM, Neuvonen PJ, Laine K, Olkkola KT (2011) Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled study. Clin Drug Investig 31:143\u2013153","journal-title":"Clin Drug Investig"},{"key":"4130_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/humu.9210","volume":"23","author":"H Fukushima-Uesaka","year":"2004","unstructured":"Fukushima-Uesaka H, Saito Y, Watanabe H, Shiseki K, Saeki M, Nakamura T, Kurose K, Sai K, Komamura K, Ueno K, Kamakura S, Kitakaze M, Hanai S, Nakajima T, Matsumoto K, Saito H, Goto YI, Kimura H, Katoh M, Sugai K, Minami N, Shirao K, Tamura T, Yamamoto N, Minami H, Ohtsu A, Yoshida T, Saijo N, Kitamura Y, Kamatani N, Ozawa S, Sawada JI (2004) Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population. Hum Mutat 23:100","journal-title":"Hum Mutat"},{"key":"4130_CR8","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/sj.bjc.6601365","volume":"89","author":"GR Lauretti","year":"2003","unstructured":"Lauretti GR, Oliveira GM, Pereira NL (2003) Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer 89:2027\u20132030","journal-title":"Br J Cancer"},{"key":"4130_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/sj.clpt.6100095","volume":"81","author":"AA Somogyi","year":"2007","unstructured":"Somogyi AA, Barratt DT, Coller JK (2007) Pharmacogenetics of opioids. Clin Pharmacol Ther 81:429\u2013444","journal-title":"Clin Pharmacol Ther"},{"key":"4130_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/sj.clpt.6100385","volume":"83","author":"D Campa","year":"2008","unstructured":"Campa D, Gioia A, Tomei A, Poli P, Barale R (2008) Association of ABCB1\/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 83:559\u2013566","journal-title":"Clin Pharmacol Ther"},{"key":"4130_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00280-009-1029-2","volume":"65","author":"K Fujita","year":"2010","unstructured":"Fujita K, Ando Y, Yamamoto W, Miya T, Endo H, Sunakawa Y, Araki K, Kodama K, Nagashima F, Ichikawa W, Narabayashi M, Akiyama Y, Kawara K, Shiomi M, Ogata H, Iwasa H, Okazaki Y, Hirose T, Sasaki Y (2010) Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer. Cancer Chemother Pharmacol 65:251\u2013258","journal-title":"Cancer Chemother Pharmacol"},{"key":"4130_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","volume":"79","author":"B Lalovic","year":"2006","unstructured":"Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD (2006) Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin Pharmacol Ther 79:461\u2013479","journal-title":"Clin Pharmacol Ther"},{"key":"4130_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00228-010-0893-3","volume":"67","author":"O Kummer","year":"2011","unstructured":"Kummer O, Hammann F, Moser C, Schaller O, Drewe J, Krahenbuhl S (2011a) Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Eur J Clin Pharmacol 67:63\u201371","journal-title":"Eur J Clin Pharmacol"},{"key":"4130_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00228-009-0726-4","volume":"66","author":"W Zhang","year":"2010","unstructured":"Zhang W, Chang YZ, Kan QC, Zhang LR, Li ZS, Lu H, Wang ZY, Chu QJ, Zhang J (2010) CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients. Eur J Clin Pharmacol 66:61\u201366","journal-title":"Eur J Clin Pharmacol"},{"key":"4130_CR15","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1177\/0269881109104932","volume":"24","author":"J Du","year":"2010","unstructured":"Du J, Zhang A, Wang L, Xuan J, Yu L, Che R et al (2010) Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients. J Psychopharmacol 24:1115\u20131120","journal-title":"J Psychopharmacol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4130-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,3]],"date-time":"2019-03-03T01:05:58Z","timestamp":1551575158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4130-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,3]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4130"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4130-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,3]]},"assertion":[{"value":"9 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Committee of Tongji Hospital. All written informed consent documents were obtained from each participant before the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}